TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11307438

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide intracanal dressing, applied for at least one week before finishing treatment at the second visit.
Number of subjects: 73

Group type: COMPARATOR
Intervention: One-visit root canal treatment without calcium hydroxide dressing.
Number of subjects: 73
Study: 9305334

Group type: EXPERIMENTAL
Intervention: Gabapentin 3,600 mg/d
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg/d
Number of subjects: 82
Study: 8339577

Group type: EXPERIMENTAL
Intervention: Cardiac output measurement by bioimpedance using the BoMed NCCOM3‐R7 monitor
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cardiac output measurement by thermodilution
Number of subjects: 50
Study: 3830245

Group type: EXPERIMENTAL
Intervention: Caffeine (oral, 5.83 mg X kg‐1 lean body weight)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (50 mg citrate)
Number of subjects: 6
Study: 31739991

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/day and Bevacizumab 10 mg/kg every 14 days on a 28-day cycle
Number of subjects: 50

Group type: COMPARATOR
Intervention: Everolimus and Bevacizumab
Number of subjects: 50
Study: 30660860

Group type: EXPERIMENTAL
Intervention: 10 s work - 4 min of rest (10:4)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 30 s work - 4 min of rest (30:4)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 10 s work - 2 min of rest (10:2)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 42
Study: 28314503

Group type: EXPERIMENTAL
Intervention: Ex vivo lung perfusion (EVLP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no EVLP)
Number of subjects: 80
Study: 26151998

Group type: EXPERIMENTAL
Intervention: Kangaroo care from the mother before, during, and after heel blood collection
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional conditions during heel blood collection
Number of subjects: 40
Study: 23239873

Group type: EXPERIMENTAL
Intervention: Eccentric training for 14 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no eccentric training)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 24
Study: 21424399

Group type: EXPERIMENTAL
Intervention: Group-based Triple P parenting skills prevention program
Number of subjects: 821
Study: 19149900

Group type: EXPERIMENTAL
Intervention: Trivalent inactivated split virus influenza vaccine (TIV)
Number of subjects: 6203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6203
Study: 17256446

Group type: EXPERIMENTAL
Intervention: Erdosteine with amoxicillin
Number of subjects: 158

Group type: COMPARATOR
Intervention: Amoxicillin-placebo combination
Number of subjects: 158
Study: 15514599

Group type: EXPERIMENTAL
Intervention: Symmetry connector (St Jude Medical, Inc, St Paul, Minn)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sutured anastomoses
Number of subjects: 46
Study: 11605922

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Isoflurane)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Sevoflurane)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Subgroup with preoperative renal impairment (Propofol)
Number of subjects: 354
Study: 9888618

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 120
Study: 7912163

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen therapy
Number of subjects: 871

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 871
Study: 2544248

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 20183661

Group type: EXPERIMENTAL
Intervention: Children's Negative Cognitive Error Questionnaire (CNCEQ)
Number of subjects: 427
Study: 417248

Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control (no granulocyte transfusions)
Number of subjects: 69
Study: 31937120

Group type: EXPERIMENTAL
Intervention: Ethanol infusion in the vein of Marshall
Number of subjects: 147

Group type: COMPARATOR
Intervention: Radiofrequency ablation
Number of subjects: 147
Study: 31706866

Group type: EXPERIMENTAL
Intervention: Grade G2 tumors
Number of subjects: 12415

Group type: EXPERIMENTAL
Intervention: Grade G3 tumors
Number of subjects: 12415

Group type: EXPERIMENTAL
Intervention: Integrated grade-specific staging system
Number of subjects: 12415
Study: 28157776

Group type: EXPERIMENTAL
Intervention: Evidence-based pain self-management program delivered by physical therapists (PTs)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group (PTs not receiving the intervention)
Number of subjects: 320
Study: 26422093

Group type: EXPERIMENTAL
Intervention: Esomeprazole 5 mg
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg (for children > 20 kg)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Esomeprazole 20 mg (for children > 20 kg)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Esomeprazole (all doses)
Number of subjects: 109
Study: 23274592

Group type: EXPERIMENTAL
Intervention: Astaxanthin (20 mg per day for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Astaxanthin
Number of subjects: 32
Study: 21482348

Group type: EXPERIMENTAL
Intervention: Low-molecular weight heparin (LMWH) dalteparin 5000 IU once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) 5000 IU subcutaneous injection
Number of subjects: 0
Study: 19241327

Group type: EXPERIMENTAL
Intervention: Scan delay of 85 sec (protocol 3 and 4)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Scan delay of 65 sec
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Scan delay of 75 sec
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Scan delay of 95 sec
Number of subjects: 57
Study: 17124241

Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 129

Group type: COMPARATOR
Intervention: Latanoprost
Number of subjects: 129
Study: 15019387

Group type: EXPERIMENTAL
Intervention: Combined peribulbar and retrobulbar anesthesia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Superomedial retrobulbar injection
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sub‐Tenon's injection
Number of subjects: 15
Study: 12038910

Group type: EXPERIMENTAL
Intervention: Written feedback from editors (intervention)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Control group (receiving other reviewers' unscored reviews and the editor's decision letter)
Number of subjects: 222
Study: 9709766

Group type: EXPERIMENTAL
Intervention: Single-zone LASIK
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Multizone LASIK
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 95
Study: 7661591

Group type: EXPERIMENTAL
Intervention: RT concomitant chemo, no maintenance (Arm 3)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: RT concomitant chemo, with maintenance (Arm 4)
Number of subjects: 673

Group type: EXPERIMENTAL
Intervention: RT alone with maintenance chemotherapy (Arm 2)
Number of subjects: 673

Group type: COMPARATOR
Intervention: RT alone (Arm 1)
Number of subjects: 673
Study: 2679865

Group type: EXPERIMENTAL
Intervention: Gestational diabetes
Number of subjects: 261

Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 261
Study: 1106350

Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31244327

Group type: EXPERIMENTAL
Intervention: Integrated programme of physical and electrical therapy
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 95
Study: 29378994

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 25
Study: 25371064

Group type: EXPERIMENTAL
Intervention: Bicycling (exercise condition)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Isometric arm and leg exercises
Number of subjects: 136

Group type: COMPARATOR
Intervention: Non-exercise condition (control)
Number of subjects: 136
Study: 23362167

Group type: EXPERIMENTAL
Intervention: Compliance-guided PEEP group
Number of subjects: 70

Group type: COMPARATOR
Intervention: FIO2-guided group
Number of subjects: 70
Study: 21215828

Group type: EXPERIMENTAL
Intervention: DTaP-IPV (Tetraxim™)
Number of subjects: 442

Group type: COMPARATOR
Intervention: DTaP and IPV vaccines (separate administration)
Number of subjects: 442
Study: 19957670

Group type: EXPERIMENTAL
Intervention: Anethol trithione
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 16848268

Group type: COMPARATOR
Intervention: Conventional film radiography
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Digital original radiography
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Digital inverse radiography
Number of subjects: 12
Study: 12931761

Group type: EXPERIMENTAL
Intervention: Ridge preservation (RP) using tetracycline hydrated freeze-dried bone allograft (FDBA) and a collagen membrane
Number of subjects: 24

Group type: COMPARATOR
Intervention: Extraction alone (EXT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ridge preservation (RP)
Number of subjects: 24
Study: 11508686

Group type: EXPERIMENTAL
Intervention: Amtolmetin guacyl (AMG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 24
Study: 9713663

Group type: EXPERIMENTAL
Intervention: Verbal advice on exercise from the family physician and a pamphlet on exercise mailed to the patient's home address.
Number of subjects: 763

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 763
Study: 7976146

Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP)
Number of subjects: 20
Study: 2512883

Group type: EXPERIMENTAL
Intervention: Thrombolytic agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coronary reperfusion
Number of subjects: 0
Study: 1119679

Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Exteriorization
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Primary colostomy
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Overall management principles
Number of subjects: 165
Study: 31109894

Group type: EXPERIMENTAL
Intervention: LNG-IUS
Number of subjects: 358

Group type: COMPARATOR
Intervention: Control
Number of subjects: 358
Study: 30199658

Group type: EXPERIMENTAL
Intervention: Day-10 surrogate Hospital Anxiety and Depression Scale score
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Patient unresponsiveness
Number of subjects: 306
Study: 26575010

Group type: EXPERIMENTAL
Intervention: McGRATH
Number of subjects: 100

Group type: COMPARATOR
Intervention: Macintosh
Number of subjects: 100
Study: 25008402

Group type: EXPERIMENTAL
Intervention: Orthopedic pillow
Number of subjects: 20

Group type: COMPARATOR
Intervention: Memory foam pillow
Number of subjects: 20

Group type: COMPARATOR
Intervention: Feather pillow
Number of subjects: 20
Study: 22505280

Group type: EXPERIMENTAL
Intervention: Open-ended non-valved PICC
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Groshong valve
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: PASV valve
Number of subjects: 102
Study: 20640501

Group type: EXPERIMENTAL
Intervention: Vitrification
Number of subjects: 262

Group type: COMPARATOR
Intervention: Slow-rate cryopreservation
Number of subjects: 262
Study: 17958944

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (once-weekly)
Number of subjects: 48
Study: 16148822

Group type: EXPERIMENTAL
Intervention: Molecular Adsorbents Recycling System (MARS)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Standard medical therapy
Number of subjects: 354
Study: 12484708

Group type: EXPERIMENTAL
Intervention: Echinacea (1-g doses six times on the first day and three times on each subsequent day for a maximum of 10 days)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Echinacea
Number of subjects: 148
Study: 9932945

Group type: EXPERIMENTAL
Intervention: Combination therapy of regular-release levodopa (rr-L-dopa) and sustained-release levodopa (sr-L-dopa)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Monotherapy with regular-release levodopa (rr-L-dopa)
Number of subjects: 30
Study: 7474027

Group type: EXPERIMENTAL
Intervention: Daily acupuncture in three auricular sites plus one body site (LI-4)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control sites within 2-3 mm of the four active sites
Number of subjects: 40
Study: 2185575

Group type: EXPERIMENTAL
Intervention: Metoprolol combined with diltiazem
Number of subjects: 32

Group type: COMPARATOR
Intervention: Metoprolol combined with nifedipine
Number of subjects: 32
Study: 375733

Group type: EXPERIMENTAL
Intervention: Topical therapy with Nonoxynol 9
Number of subjects: 69

Group type: COMPARATOR
Intervention: Initial genital HSV infection
Number of subjects: 69

Group type: COMPARATOR
Intervention: Initial infections
Number of subjects: 69

Group type: COMPARATOR
Intervention: Type 1 HSV
Number of subjects: 69

Group type: COMPARATOR
Intervention: Clinical recurrences
Number of subjects: 69

Group type: COMPARATOR
Intervention: Papanicolaou smears
Number of subjects: 69

Group type: COMPARATOR
Intervention: Cytologic smears
Number of subjects: 69

Group type: COMPARATOR
Intervention: Serology
Number of subjects: 69
Study: 30836166

Group type: EXPERIMENTAL
Intervention: 78 Gy in 39 fractions of photon radiation therapy
Number of subjects: 301

Group type: COMPARATOR
Intervention: 70 Gy in 35 fractions of photon radiation therapy
Number of subjects: 301
Study: 27705097

Group type: EXPERIMENTAL
Intervention: Transareola single-site endoscopic thyroidectomy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Three-port endoscopic thyroidectomy
Number of subjects: 40
Study: 26500170

Group type: EXPERIMENTAL
Intervention: CSM referral letter alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSM referral letter + DIG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced CSM referral letter alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduced CSM referral letter + DIG
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard (control) referral
Number of subjects: 0
Study: 24285599

Group type: EXPERIMENTAL
Intervention: 3 g fish oil/day (540 mg eicosapentaenoic acid + 360 mg docosahexaenoic acid)
Number of subjects: 83

Group type: COMPARATOR
Intervention: 3 g soy oil/day (placebo)
Number of subjects: 83
Study: 22990031

Group type: COMPARATOR
Intervention: Calcium carbonate supplementation (1000 mg Ca/d, 5 d/wk) for 12 months
Number of subjects: 160
Study: 20149038

Group type: EXPERIMENTAL
Intervention: Acute oral hydration
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 44
Study: 17316154

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa administered weekly, every 2 weeks, and every 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (weight-based and fixed dosing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa at extended dosing intervals of at least 3 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 0
Study: 15182768

Group type: EXPERIMENTAL
Intervention: Doppler indices of transmitral flow measurements
Number of subjects: 355
Study: 11579362

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Candesartan and Enalapril combination
Number of subjects: 768

Group type: EXPERIMENTAL
Intervention: Enalapril alone
Number of subjects: 768

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 768

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 768
Study: 9833602

Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 10 min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 30 min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 100 min
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide administered at a constant-rate intravenous infusion for 300 min
Number of subjects: 8
Study: 10471100

Group type: EXPERIMENTAL
Intervention: rgp160 + zidovudine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: rgp160 + placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: zidovudine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: rgp160
Number of subjects: 40
Study: 2051246

Group type: EXPERIMENTAL
Intervention: Hand articulation of the casts prior to mounting the lower cast against the upper cast
Number of subjects: 53

Group type: COMPARATOR
Intervention: Low‐viscosity polyether interdental registration material
Number of subjects: 53
Study: 6188739

Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B
Number of subjects: 230

Group type: COMPARATOR
Intervention: Neomycin-polymyxin B-gramicidin
Number of subjects: 230

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 230
Study: 28445230

Group type: EXPERIMENTAL
Intervention: Unilateral Plyometric Training (U)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Bilateral Plyometric Training (B)
Number of subjects: 15
Study: 30231173

Group type: EXPERIMENTAL
Intervention: 1% HA gel
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (blood clot)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 26511668

Group type: EXPERIMENTAL
Intervention: neoadjuvant chemoradiotherapy and surgery (nCRTS)
Number of subjects: 170

Group type: COMPARATOR
Intervention: surgery alone
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: adenocarcinoma
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: squamous cell cancer
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: ypT0N0 category
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: node-positive disease
Number of subjects: 170
Study: 24583615

Group type: EXPERIMENTAL
Intervention: Shang Ring
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional
Number of subjects: 400

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 400
Study: 23212497

Group type: EXPERIMENTAL
Intervention: 2-week rotations
Number of subjects: 62

Group type: COMPARATOR
Intervention: 4-week rotations
Number of subjects: 62
Study: 20693270

Group type: EXPERIMENTAL
Intervention: SCH351125 (oral CCR5 inhibitor)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 19049265

Group type: EXPERIMENTAL
Intervention: 0.5% moxifloxacin (MFLX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.3% gatifloxacin (GFLX)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5% levofloxacin (LVFX)
Number of subjects: 0
Study: 16466171

Group type: EXPERIMENTAL
Intervention: Daidzein Tablets for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional medicine
Number of subjects: 40
Study: 12825038

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid nasal dressing (MeroGel)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Nonabsorbable packing (Merocel)
Number of subjects: 37
Study: 10648312

Group type: EXPERIMENTAL
Intervention: Dimenhydrinate suppositories
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 9081681

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 8382708

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg tirilazad mesylate
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg tirilazad mesylate
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg tirilazad mesylate
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2.0 mg/kg tirilazad mesylate
Number of subjects: 47

Group type: COMPARATOR
Intervention: Citrate vehicle
Number of subjects: 47
Study: 2876337

Group type: EXPERIMENTAL
Intervention: Artificial food additives
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal diet re-introduced after additive-free diet
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Aspirin sensitivity
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Atopy prevalence
Number of subjects: 43
Study: 30900668

Group type: EXPERIMENTAL
Intervention: Bleaching + 10% sodium ascorbate (antioxidant)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bleaching + green tea
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bleaching + white tea
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bleaching only
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (no bleaching)
Number of subjects: 50
Study: 30594335

Group type: EXPERIMENTAL
Intervention: Manual therapy including neurodynamic techniques (MT), conducted twice weekly for 20 therapy sessions.
Number of subjects: 189

Group type: COMPARATOR
Intervention: Control group (CG; without therapy).
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Manual therapy including neurodynamic techniques (MT).
Number of subjects: 189
Study: 26292798

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg twice a day for 3 months
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (not treated with Omeprazole)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: RSI-CH
Number of subjects: 107
Study: 23890962

Group type: EXPERIMENTAL
Intervention: Endoscopic thyroidectomy using the oral vestibular approach (ETOVA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Endoscopic thyroidectomy by areola approach (ETAA)
Number of subjects: 24
Study: 23084677

Group type: EXPERIMENTAL
Intervention: Alginate carboxymethylcellulose hyaluronic acid (ACH)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Carboxymethylcellulose hyaluronic acid (CH)
Number of subjects: 187